ABSTRACT The goal of this review is to evaluate the efficacy of commonly available dietary supplements in the treatment of hypertension, using the average blood pressure reduction achieved with the implementation of lifestyle modifications as a standard. For this reason, the authors focus on the antihypertensive potential of these agents rather than pharmacology, pharmacokinetics, adverse effects, or supplement ñ drug interactions. For the purpose of this review, dietary supplements are defined as exhibiting some evidence of benefit if a systolic blood pressure reduction of 9.0 mm Hg or greater and/or a diastolic blood pressure reduction of 5.0 mm Hg or greater has been observed in previously published, peer-reviewed trials. These defining limits are based on the average blood pressure reduction associated with the implementation of certain lifestyle modifications. Agents with some evidence of benefit include coenzyme Q10, fish oil, garlic, vitamin C, and L-arginine. J Clin Hypertens (2004) 6;5:242-248
- Home
- About
- Find a Doctor
- Membership
- Education
- News
- Newsletter
- Conventions & Symposiums
- Webinars
- Positive Press (F4CP) ↪
- Insurance and Medicare ⚿
- New Practitioners ⚿
- Center for Excellence ⚿
- Informative Links
- Mandated Reporter Training↪
- Leadership
- Officers and Regional Directors
- Districts
- District Officers ⚿
- District Map
- District 1 (Manhattan)
- District 2 (Brooklyn)
- District 3 (Queens)
- District 4 (Bronx)
- District 5 (Staten Island)
- District 6 (Nassau)
- District 7 (Suffolk)
- District 8 (Westchester)
- District 9 (Mid-Hudson)
- District 10 (Capital Region)
- District 11 (Mohawk Valley)
- District 12 (Central NY)
- District 13 (Binghamton Area)
- District 14 (Rockland County)
- District 15 (Finger Lakes)
- District 16 (Southern Tier)
- District 17 (Western NY)
- Committees
- Bylaws ⚿
- Code of Ethics ⚿
- Elections ⚿
- Advocacy
- Sponsors
- Classifieds